Assembly Biosciences (ASMB) Profit After Tax (2010 - 2026)
Assembly Biosciences' (ASMB) quarterly Profit After Tax came in at -$9.1 million in Q1 2026, down 2.47% year-on-year from -$9.3 million in Q1 2025, and down 141.1% quarter-over-quarter from $22.1 million in Q4 2025.
Assembly Biosciences (ASMB) Profit After Tax (2010 - 2026) Analysis & Trends
Assembly Biosciences' Profit After Tax history runs 17 years deep, the most recent figure standing at -$9.1 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 2.47% year-over-year to -$9.1 million in Q1 2026; TTM through Mar 2026 was -$6.4 million, a 84.02% increase from a year earlier, with the FY2025 full-year figure at -$6.1 million, up 84.81% from the prior year.
- Profit After Tax eased to -$9.1 million in Q1 2026 per ASMB's latest filing, from $22.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at $22.1 million in Q4 2025 and bottomed at -$24.5 million in Q2 2022.
- The 5-year median for Profit After Tax is -$10.8 million (2023), against an average of -$12.3 million.
- Across the five-year window, Profit After Tax decreased 22.99% in 2022 and jumped 312.61% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$22.2 million in 2022, then jumped by 51.49% to -$10.8 million in 2023, then advanced by 3.51% to -$10.4 million in 2024, then soared by 312.61% to $22.1 million in 2025, then plunged by 141.1% to -$9.1 million in 2026.
- Per Business Quant, the three latest ASMB Profit After Tax figures stand at -$9.1 million (Q1 2026), $22.1 million (Q4 2025), and -$9.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Assembly Biosciences | 282.74 Mn | 56.14 Mn | - | -9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.08 Mn |
| Dec 31, 2025 | 22.09 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Jun 30, 2025 | -10.20 Mn |
| Mar 31, 2025 | -8.86 Mn |
| Dec 31, 2024 | -10.39 Mn |
| Sep 30, 2024 | -9.48 Mn |
| Jun 30, 2024 | -11.21 Mn |
| Mar 31, 2024 | -9.08 Mn |
| Dec 31, 2023 | -10.77 Mn |
| Sep 30, 2023 | -14.42 Mn |
| Jun 30, 2023 | -16.90 Mn |
| Mar 31, 2023 | -18.95 Mn |
| Dec 31, 2022 | -22.20 Mn |
| Sep 30, 2022 | -23.15 Mn |
| Jun 30, 2022 | -24.46 Mn |
| Mar 31, 2022 | -23.09 Mn |
| Dec 31, 2021 | -60.26 Mn |
| Sep 30, 2021 | -18.82 Mn |
| Jun 30, 2021 | -23.60 Mn |